7UI5

Evolution avoids a pathological stabilizing interaction in the immune protein S100A9

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
2	2D 1H-13C HSQC	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
3	3D HNCA	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
4	3D HNCACB	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
5	3D HNCO	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
6	3D HN(CA)CO	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
7	HN(CO)CACB	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
8	3D 1H-13C 1H-15N NOESY	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
9	3D HNHA	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
10	2D HDCB	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
11	2D HECB	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
12	3D HCCH-TOCSY	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800
13	3D CCH-TOCSY	25 mM TRIS, 100 mM sodium chloride, 10 mM calcium chloride, 1 mM [U-100% 13C; U-100% 15N] S100A9-M63F	90% H2O/10% D2O	110 mM	7.4	1.01 bar	298	Bruker AVANCE III HD 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	800

NMR Refinement
Method	Details	Software
simulated annealing

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	NMRView		Johnson, One Moon Scientific
4	peak picking	NMRView		Johnson, One Moon Scientific

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.